Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A flexible modeling approach for biomarker‐based computation of absolute risk of Alzheimer's disease dementia

Alzheimer s & Dementia(2022)10.1002/alz.12781Source: DataRank Database

A flexible modeling approach for biomarker‐based computation of absolute risk of Alzheimer's disease dementia is a research paper published in Alzheimer s & Dementia (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (48 grants)Impact (FWCI 0.70)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Jessica Mozersky ORCID,Suzanne E. Schindler ORCID,Erin Linnenbringer ORCID,Junwei Wang ORCID,Brian A. Gordon ORCID

Live enrichment

PubMed:36178120 PMC:PMC10060442 OpenAlex:https://openalex.org/W4298088476

National Institutes of Health

Grant: R01 AG065234

National Institutes of Health

Grant: P01 AG026276

National Institutes of Health

Grant: 5 P01 AG003991

National Institutes of Health

Grant: P30 AG066444

National Institutes of Health

Grant: 1 UL1 TR002345

National Institutes of Health

Grant: R44 AG059489

BrightFocus Foundation

Grant: CA2016636

Alzheimer's Drug Discovery Foundation

Grant: GC‐201711‐ 2013978

NIA NIH HHS

Grant: K01 AG053474

NIA NIH HHS

Grant: P30 AG072947

NIA NIH HHS

Grant: P50 AG005133

NIA NIH HHS

Grant: P50 AG047270

NIA NIH HHS

Grant: P30 AG010124

NIA NIH HHS

Grant: P30 AG013854

NIA NIH HHS

Grant: P30 AG053760

NIA NIH HHS

Grant: P30 AG062428

NIA NIH HHS

Grant: P50 AG047366

NIA NIH HHS

Grant: R01 AG070941

NIA NIH HHS

Grant: P30 AG013846

NIA NIH HHS

Grant: P30 AG019610

NIA NIH HHS

Grant: P30 AG049638

NIA NIH HHS

Grant: P50 AG016573

NIA NIH HHS

Grant: P30 AG035982

NIA NIH HHS

Grant: P50 AG005138

NIA NIH HHS

Grant: P50 AG025688

NIA NIH HHS

Grant: P30 AG008017

NIA NIH HHS

Grant: P30 AG028383

NIA NIH HHS

Grant: P30 AG072977

NIA NIH HHS

Grant: P50 AG005142

NIAAA NIH HHS

Grant: R01 AA029308

NIA NIH HHS

Grant: P30 AG008051

NIA NIH HHS

Grant: P30 AG010133

NIA NIH HHS

Grant: P30 AG062429

NIA NIH HHS

Grant: P50 AG005136

NIA NIH HHS

Grant: P50 AG005146

NIA NIH HHS

Grant: P50 AG023501

NIA NIH HHS

Grant: P50 AG047266

NIA NIH HHS

Grant: P01 AG003991

NIA NIH HHS

Grant: P30 AG010129

NIA NIH HHS

Grant: P30 AG010161

NIA NIH HHS

Grant: P30 AG012300

NIA NIH HHS

Grant: P30 AG062422

NIA NIH HHS

Grant: P50 AG008702

NIH HHS

Grant: S10 OD025214

NIA NIH HHS

Grant: U01 AG016976

NIA NIH HHS

Grant: P30 AG062421

NIA NIH HHS

Grant: P30 AG062715

NCATS NIH HHS

Grant: UL1 TR002345

FWCI

0.70

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10060442/pdf/nihms-1828729.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12781

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.12781

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12781

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsIntracerebral and Subarachnoid Hemorrhage ResearchHumansAgedAlzheimer DiseaseAmyloid beta-PeptidesCognitive DysfunctionBiomarkersPositron-Emission Tomographytau Proteins

MeSH Terms

AgedAlzheimer DiseaseHumansBiomarkersAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyCognitive Dysfunction

Keywords

DementiaReceiver operating characteristicHazard ratioApolipoprotein EAlzheimer's Disease Neuroimaging InitiativeBiomarkerAlzheimer's diseaseInternal medicineOncologyMagnetic resonance imagingMedicineDiseasePsychologyConfidence intervalRadiologyBiologySurvival analysisRisk EstimationReturn Of Research Results

Sustainable Development Goals

SDG 0: Good health and well-being